Hear CEO of Generate:Biomedicines and Flagship Pioneering CEO-Partner Mike Nally share updates on Generate and why the company may have the "Mona Lisa of molecules" when it comes to treating mild-to-moderate asthma. More from Flagship @ JPM2024 here.
Related Companies
- Generate:Biomedicines Founded: 2018
